ChromoGenics expands to Denmark and appoints Michael Felthaus to drive sales
Michael Felthaus has been appointed Business developer and will be responsible for sales in Denmark. This appointment reflects ChromoGenics’ strong ambition to expand its operations outside Sweden.
Michael has a solid sales and business development background with more than 20 years of various positions within dynamic façade solutions in the glass as well as in the solar control industry. He has several years at WindowMaster, a part of VKR INWIDO/Art Andersen.
“We are pleased to have Michael joining us to expand our business into Denmark. Michael brings proven successful sales development from the window and glass industry,” says Peter Lundh, Head of Sales at ChromoGenics. “We are in an exciting expansion phase and together with Michael we will aggressively launch our product ConverLight™ to the Danish market.”
"I am excited to join ChromoGenics,” says Michael Felthaus. "ConverLight™ is well positioned to provide real estate owners, architects and construction companies with sustainable dynamic glass solutions that also contributes to environmental certifications. There is a great interest in the product and I look forward to contributing to the continued success of ChromoGenics,” concludes Michael.
Contact:
Thomas Almesjö, CEO
Susanne Andersson, CFO & Head of Communications
Tel: +46 18 430 0430
E-mail: info@chromogenics.com
About ChromoGenics
ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com
Tags:
